Clinical Trial: Mapping the Enhanced Landscape of Advanced Breast Cancer fOr DYnamic Treatment Approaches

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07893730) titled 'Mapping the Enhanced Landscape of Advanced Breast Cancer fOr DYnamic Treatment Approaches' on Oct. 13.

Brief Summary: MELODY is a prospective, single-arm phase II study introducing routine liquid-biopsy next-generation sequencing for patients with advanced or unresectable breast cancer in Ireland. The study will characterise genomic alterations detected in plasma and tumour tissue, assess concordance and clinical actionability, and evaluate clinical, operational, economic, patient-reported and exploratory translational outcomes.

Study Start Date: Oct. 10

Study Type: INTERVENTIONAL

Condition: Breast Cancer Metastatic Breast Cance...